Targeting human coatomer subunit zeta-1 by a marine natural product derivative represents a new therapeutic strategy to inhibit enterovirus A71 replication
This study is spearheaded by researcher Wu Zhong (National Engineering Research Center for the Emergence Drugs, Beijing Institute of Pharmacology and...
